LY-364947

CAS No. 396129-53-6

LY-364947( HTS 466284 | TGF-β RI Kinase Inhibitor )

Catalog No. M14364 CAS No. 396129-53-6

LY364947 is a potent ATP-competitive inhibitor of TGFβR-I with IC50 of 59 nM in a cell-free assay, shows 7-fold selectivity over TGFβR-II.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 63 In Stock
5MG 56 In Stock
10MG 71 In Stock
25MG 139 In Stock
50MG 249 In Stock
100MG 365 In Stock
200MG 548 In Stock
500MG 858 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    LY-364947
  • Note
    Research use only, not for human use.
  • Brief Description
    LY364947 is a potent ATP-competitive inhibitor of TGFβR-I with IC50 of 59 nM in a cell-free assay, shows 7-fold selectivity over TGFβR-II.
  • Description
    LY364947 is a potent ATP-competitive inhibitor of TGFβR-I with IC50 of 59 nM in a cell-free assay, shows 7-fold selectivity over TGFβR-II.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    HTS 466284 | TGF-β RI Kinase Inhibitor
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Casein Kinase
  • Recptor
    CK1δ| MLK-7K| TGFβRI| TGFβRII| RIPK2
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    396129-53-6
  • Formula Weight
    272.3
  • Molecular Formula
    C17H12N4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 1 mg/mL (3.67 mM)
  • SMILES
    C1(C2=CNN=C2C3=NC=CC=C3)=CC=NC4=CC=CC=C14
  • Chemical Name
    4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)quinoline

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Li HY, et al. J Med Chem, 2006, 49(6), 2138-2142.
molnova catalog
related products
  • Longdaysin

    Longdaysin is an inhibitor of CK1α and CK1δ (IC50s: 5.6/8.8 μM). It also can inhibit ERK2 (IC50: 52 μM).

  • PF-5006739

    A potent, selective casein kinase CK1δ/ε inhibitor with IC50 of 3.9/17.0 nM, respectively.

  • WAY-296817

    WAY-296817 is casein kinase 1 (CK1) inhibitor and can be used for research on the treatment or prevention of diseases associated with circadiantiazol rhythm, inflammation diseases.